GLP-1 Medicines and the Overlooked Role of Nutrition in Weight Management
GLP-1 medicines have changed the way many people manage obesity by helping reduce hunger and support weight loss. However,…
-
-
Vivani’s Semaglutide Implant Aims to Solve GLP-1 Treatment Discontinuation
Sustaining long-term weight loss with GLP-1 medications is a tough challenge. Patients often stop treatment because of side effects,…
-
Online GLP-1 Sellers Often Bypass Meaningful Clinician Oversight
Direct-to-consumer telehealth platforms have changed how people access glucagon-like peptide-1 receptor agonists for managing obesity. A recent secret shopper…
-
GLP-1 Use Among Americans Reaches New Peak
Recent polling data indicates that patient utilization of GLP-1 medications has reached its highest historical level. Eleven percent of…
-
Beverage Makers Redesign Packaging to Meet Growing GLP-1 Demand
Beverage companies are changing package sizes and messaging as GLP-1 receptor agonist medications alter consumer drinking habits. Industry analysts…
-
GLP-1 Receptor Agonists and Urinary Incontinence in Women With Obesity and Type 2 Diabetes
Urinary incontinence affects a significant number of women who are obese and have type 2 diabetes. Extra body fat…
-
Pre-Pregnancy GLP-1 Therapy and Gestational Diabetes: Why Discontinuation Timing Matters
Glucagon-like peptide-1 receptor agonists and tirzepatide have changed how we manage obesity and type 2 diabetes. As a result,…
-
Novo Nordisk Oral Wegovy Strengthens Obesity Market
Novo Nordisk recorded over three million prescriptions for oral Wegovy within five months of its availability. Financial analysts gave…
-
Seven Pharmacological Options for Weight Management
Obesity affects many adults today. It leads directly to heart disease, diabetes, and joint pain. Because of this, doctors…
-
How to Exercise on GLP-1 Medications: A Clinical Guide
Glucagon-like peptide-1 receptor agonists have changed the way we treat obesity and type 2 diabetes. Medications like semaglutide and…
